Nautilus Biotechnology
Nautilus is a Washington based biomedical research company that develops a platform for analyzing and quantifying the human proteome.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed Nautilus Biotechnology Information
Geographic Data
Address: 2701 Eastlake Avenue East
City: Seattle
State: WA
Zip: 98102
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$200M
Raised Total:$103M
Social
Metrics
2,296,089Website Global Rank
8,183Website Monthly Traffic
Twitter Followers
Description
Nautilus is a Washington based biomedical research company that develops a platform for analyzing and quantifying the human proteome.
Contact Phone:
+12063332001
Contact Email:
Nautilus Biotechnology went public on 6/9/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/9/2021
IPO Valuation:
$900M
Ticker Symbol:
NAUT
Amount Raised:
$345M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
